Biotech and Pharmaceuticals – Page 3 – Finance Tailwind

Eli Lilly weight loss pill orforglipron clears trial, paving way for approval

Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug

Fujifilm Holly Springs pharma factory readies open with J&J, Regeneron

FDA approves Signos glucose monitoring for weight loss

Viking Therapeutics falls 30% on drug data

Novo Nordisk offers diabetes drug Ozempic for steep cash discount

Eli Lilly hikes price of Mounjaro in UK amid Trump pressure

FDA may pull authorization of Pfizer Covid shot for children under 5

Eli Lilly obesity pill orforglipron led to 12% weight loss

Eli Lilly (LLY) Q2 2025 earnings report